DEF 14A: AlphaVest Seeks Extension for Business Combination Deadline

Sentiment:

Proxy Statement for Extension


AlphaVest Acquisition Corp. is seeking shareholder approval to extend its business combination deadline by up to four months, pushing the new target to January 22, 2026, to finalize a merger or find a new target.

Delay expectedThe filing explicitly states that the purpose of the proposals is to allow AlphaVest additional time and flexibility to complete its previously announced Business Combination, or an initial business combination if the current one is not consummated.The company is seeking to extend the Combination Period from September 22, 2025, to January 22, 2026, due to the belief that the current Termination Date will not provide sufficient time.
Capital raiseThe Sponsor or its affiliates/designees will deposit $55,000 into the Trust Account for each one-month extension period.In exchange for these deposits, the Sponsor will receive a non-interest bearing, unsecured promissory note, payable upon the consummation of a Business Combination.
Worse than expectedAlphaVest has not been able to complete a business combination by its original deadline of September 22, 2025, indicating a delay in its primary objective.The need for an extension suggests that the company's initial timeline or ability to secure a definitive deal was not met as anticipated.

Summary

  • AlphaVest Acquisition Corp. (AlphaVest) is a Cayman Islands exempted company formed on January 14, 2022, as a blank check company to effect a business combination.
  • The company is seeking shareholder approval for three proposals at an Extraordinary General Meeting on September 19, 2025: an Extension Amendment, a Trust Agreement Amendment, and an Adjournment Proposal.
  • The Extension Amendment Proposal aims to amend AlphaVest's charter to extend the deadline for consummating a business combination from September 22, 2025, up to four additional one-month periods, until January 22, 2026.
  • The Trust Agreement Amendment Proposal seeks to amend the investment management trust agreement to allow these extensions, requiring the Sponsor to deposit $55,000 into the Trust Account for each one-month extension.
  • AlphaVest entered into a business combination agreement with AV Merger Sub, Inc. and AMC Corporation on August 16, 2024, with a separate shareholder meeting for this combination scheduled for September 5, 2025.
  • Public shareholders have the right to redeem their Public Shares for cash at approximately $11.99 per share, based on the Trust Account balance of $18,876,141.50 as of the Record Date (August 22, 2025), regardless of how they vote on the extension proposals.
  • The Board of Directors unanimously recommends voting FOR all three proposals, believing the current deadline is insufficient to complete a business combination.
  • Approval of the Extension Amendment Proposal requires a special resolution (two-thirds of votes cast by shares present and entitled to vote), while the Trust Agreement Amendment Proposal requires the affirmative vote of at least 65% of the then outstanding Ordinary Shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company is facing a delay in completing its business combination, it is proactively seeking an extension to continue its efforts and has a redemption option for shareholders, providing a floor to the share price. The existence of a current business combination agreement (with AMC) provides some positive outlook, despite the uncertainty of its consummation.

Positives

  • The proposed extension provides AlphaVest with additional time (up to four months, until January 22, 2026) to complete its previously announced business combination with AMC Corporation or identify an alternative target.
  • Public shareholders who do not wish to extend the termination date have the opportunity to redeem their shares for cash at approximately $11.99 per share, which is slightly higher than the market price of $11.97 on the Record Date.
  • The Sponsor's commitment to fund the $55,000 per month extension payments, in exchange for a non-interest bearing promissory note, demonstrates continued support for the company's efforts to find a business combination.

Negatives

  • AlphaVest has been unable to consummate a business combination by its original September 22, 2025, deadline, necessitating this extension request.
  • There is no guarantee that even with the extension, AlphaVest will be able to consummate a business combination by the new deadline of January 22, 2026.
  • Significant redemptions by public shareholders could reduce the funds available in the Trust Account, potentially making the company less attractive to a target business or leaving insufficient cash to complete a transaction.
  • If the extension proposals are not approved and a business combination is not consummated, AlphaVest will liquidate, resulting in the Public Shares being redeemed, and the Founder Shares and Public Rights expiring worthless.
  • The interests of the Sponsor, directors, and officers in completing a business combination (to avoid their Founder Shares and Private Placement Units becoming worthless) may differ from those of public shareholders.

Risks

  • No assurance that the Extension Amendment, Trust Agreement Amendment, and Extensions will enable the company to complete an initial Business Combination.
  • Redemptions may leave insufficient cash to consummate an initial Business Combination on commercially acceptable terms, or at all.
  • Shareholders may be unable to recover their investment except through sales of shares on the open market, and the price of shares may be volatile.
  • New SEC rules (SPAC Rules) may increase costs and time needed to complete a business combination, or force earlier liquidation.
  • The company could be deemed an investment company under the Investment Company Act, leading to burdensome compliance requirements, severe activity restrictions, or liquidation.
  • Inability to complete a business combination with a foreign target if it becomes subject to review or approval by regulatory authorities (e.g., CFIUS) pursuant to U.S. or foreign laws or regulations.
  • The Sponsor's major shareholder being a non-U.S. person and a majority of officers/directors having ties to the Peoples Republic of China may limit the pool of acquisition candidates, especially U.S. targets, due to foreign investment regulations and CFIUS review.
  • Nasdaq may delist the company's securities if shareholder redemptions cause the company to no longer meet continued listing requirements, leading to limited market quotations, reduced liquidity, and other adverse consequences.

Future Outlook

AlphaVest intends to continue its efforts to consummate a business combination until the last Extended Date of January 22, 2026, if the proposed extensions are approved. The company will remain a reporting company under the Exchange Act, and its securities will continue to be publicly traded during this period. A separate shareholder meeting is scheduled for September 5, 2025, to vote on the previously announced business combination with AMC Corporation.

Management Comments

  • The Board has determined that it is in the best interests of AlphaVest to seek an extension of the Termination Date and have AlphaVest shareholders approve the Extension Amendment Proposal and the Trust Agreement Amendment Proposal to allow for additional time to consummate a Business Combination.
  • The Board believes that the current Termination Date will not provide sufficient time to complete a Business Combination.
  • Given AlphaVest's commitment of time, effort and financial resources to date with respect to identifying a Business Combination target, circumstances warrant providing shareholders with additional time and opportunity to consider a prospective Business Combination.

Industry Context

The filing highlights the increasing regulatory scrutiny on Special Purpose Acquisition Companies (SPACs), particularly with the SEC's recently adopted SPAC Rules. These rules may increase costs and time for business combinations and could potentially subject SPACs to regulation under the Investment Company Act of 1940, which would severely restrict activities and potentially force liquidation. Additionally, the company's ties to the Peoples Republic of China and its non-U.S. major shareholder introduce foreign investment review risks, such as by CFIUS, which could limit the pool of potential U.S. target companies and complicate deal completion.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Charter AmendmentProposed amendment to AlphaVest's Second Amended and Restated Memorandum and Articles of Association to extend the date by which the company must consummate a business combination from September 22, 2025, to January 22, 2026.Upon shareholder approval and filing with Cayman Islands Registrar of CompaniesProvides additional time for the company to complete a business combination, but also allows public shareholders to redeem their shares if they do not wish to continue their investment.
Trust Agreement AmendmentProposed amendment to AlphaVest's Investment Management Trust Agreement to allow for the extension of the termination date by depositing $55,000 per one-month extension into the Trust Account.Upon shareholder approval and execution of the amendmentFacilitates the extension of the business combination period, with the Sponsor bearing the cost of extensions, receiving a non-interest bearing promissory note.

Related Party Transactions

  • AlphaVest's Sponsor, AlphaVest Holding LP, and its affiliates or designees are responsible for depositing $55,000 into the Trust Account for each one-month extension period, in exchange for a non-interest bearing, unsecured promissory note.
  • The initial shareholders (Sponsor, directors, and officers) own Founder Shares (acquired for $25,000, with a market value of $22,144,500 as of the Record Date) and Private Placement Units, which would become worthless if a business combination is not consummated and the company liquidates.
  • The Sponsor has agreed to be liable for claims by third parties that reduce the Trust Account below a certain threshold, except for claims from parties who waive access to the Trust Account.

Stakeholder Impact

  • Shareholders: Public shareholders can choose to redeem their shares at approximately $11.99 per share, providing a downside protection, or hold their shares for potential upside if a business combination is successfully completed. However, there is a risk of losing their investment if the company liquidates.
  • Sponsor and Initial Shareholders: Their investment in Founder Shares and Private Placement Units is at risk if a business combination is not completed. They have a strong incentive to see a business combination through.
  • Creditors: In the event of liquidation, claims of creditors may take priority over the claims of public shareholders, potentially reducing the amount distributed to shareholders.

Next Steps

  • Hold an Extraordinary General Meeting on September 19, 2025, for shareholders to vote on the Extension Amendment, Trust Agreement Amendment, and Adjournment Proposals.
  • If approved, AlphaVest will file the amended charter and trust agreement with the Cayman Islands Registrar of Companies.
  • Continue efforts to consummate a business combination with AMC Corporation or another target by the extended deadline of January 22, 2026.
  • Hold a separate Extraordinary General Meeting of Shareholders, currently scheduled for September 5, 2025, to vote on the business combination with AMC Corporation and related proposals.

Key Dates

DateDescription
2022-01-14AlphaVest Acquisition Corp. incorporated.
2022-12-19Investment Management Trust Agreement dated; IPO registration statement declared effective by SEC.
2022-12-20Final prospectus filed in connection with the IPO.
2022-12-22Initial Public Offering (IPO) consummated.
2022-12-29EarlyBirdCapital, Inc. exercised its over-allotment option.
2023-12-21Second Amended and Restated Memorandum and Articles of Association dated.
2024-08-16Business combination agreement entered into with AV Merger Sub, Inc. and AMC Corporation.
2024-11-14Mizuho Financial Group, Inc. Schedule 13G filed with SEC.
2024-12-18Amendment to Existing Charter dated.
2024-12-31Year ended for Annual Report on Form 10-K.
2025-02-14Karpus Management, Inc. Schedule 13G filed with SEC.
2025-03-31Period ended for Quarterly Report on Form 10-Q.
2025-04-14Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC.
2025-05-20Quarterly Report on Form 10-Q for the period ended March 31, 2025, filed with the SEC.
2025-06-30Period ended for Quarterly Report on Form 10-Q.
2025-08-14Quarterly Report on Form 10-Q for the period ended June 30, 2025, filed with the SEC.
2025-08-22Record Date for determining shareholders entitled to vote at the Extraordinary General Meeting.
2025-09-02Proxy Statement dated and first mailed to shareholders.
2025-09-05Extraordinary General Meeting of Shareholders currently scheduled to vote on the Business Combination with AMC.
2025-09-12Deadline for shareholders to request proxy materials.
2025-09-17Deadline (5:00 p.m. ET) for virtual meeting registration and redemption requests.
2025-09-18Deadline (11:59 p.m. ET) for mail-in proxy votes.
2025-09-19Extraordinary General Meeting date (9:30 a.m. ET) to vote on extension proposals.
2025-09-22Current Termination Date for consummating a Business Combination.
2026-01-22Proposed last Extended Date for consummating a Business Combination if extensions are approved.

Recommendation

hold

A 'hold' recommendation is appropriate given the current situation. The company is seeking an extension because it has not yet completed a business combination, which is a negative. However, it has a proposed business combination with AMC Corporation and is actively working to finalize a deal. Public shareholders have the option to redeem their shares at a price close to the current market value, providing a downside floor. This allows investors to either exit with minimal loss or hold for the potential upside if a successful business combination is achieved within the extended timeframe, while being aware of the inherent risks of SPACs and the specific challenges outlined in the filing.

Keywords

SPAC, AlphaVest, Acquisition, Merger, Extension, Proxy Statement, SEC Filing, Business Combination, Redemption Rights, Trust Account, Corporate Governance, Shareholder Vote, AMC Corporation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.